Review: taking Dilantin and Atarax together


Summary

Drug interactions are reported among people who take Dilantin and Atarax together. This review analyzes the effectiveness and drug interactions between Dilantin and Atarax. It is created by eHealthMe based on reports of 397 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Dilantin

Dilantin has active ingredients of phenytoin. It is often used in convulsion. (latest outcomes from Dilantin 4,822 users)

Atarax

Atarax has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. (latest outcomes from Atarax 14,420 users)

On Sep, 19, 2016

397 people who take Dilantin, Atarax are studied.


Number of reports submitted per year:

Dilantin and Atarax drug interactions.

Drug effectiveness over time:

Dilantin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Atarax:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Dilantin:
  • female: 100.0% - (2 of 2 people)
  • male: 0.0% - (0 of 0 people)
Atarax:
  • female: 0.0% - (0 of 2 people)
  • male: 0.0% - (0 of 0 people)

Drug effectiveness by age:

Dilantin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Atarax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 1 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • pyrexia
  • hepatic function abnormal
  • stevens-johnson syndrome
  • toxic epidermal necrolysis
  • acute lymphocytic leukaemia recurrent
  • aspartate aminotransferase increased
  • blood creatinine increased
  • blood pressure decreased
  • c-reactive protein increased
  • capillary leak syndrome
1 - 6 months:
  • cardiac tamponade
  • pericardial effusion
  • cardiac arrest
  • disseminated intravascular coagulation
  • fatigue
  • supraventricular tachycardia
  • weakness
  • cytomegalovirus infection
  • leukocytosis
  • multi-organ failure
6 - 12 months:
  • deep vein thrombosis
  • emotional distress
  • femur fracture
  • infarction
  • mental disorder
  • pain
  • pulmonary embolism
1 - 2 years:
  • pain
  • abdominal pain
  • acute sinusitis
  • alopecia
  • anaemia
  • arthropathy
  • asthma
  • blood alkaline phosphatase increased
  • blood creatine phosphokinase abnormal
  • breast mass
2 - 5 years:
  • fall
  • liver disorder
  • pancreatitis acute
  • tremor
  • abdominal pain
  • acute sinusitis
  • alcoholism
  • alopecia
  • anaemia
  • arthropathy
5 - 10 years:
  • abdominal pain
  • anaphylaxis
  • genital haemorrhage
  • hives
  • injury
  • menorrhagia
  • pelvic inflammatory disease
  • suicidal ideation
  • vaginal haemorrhage
10+ years:
  • anxiety
  • bladder disorder
  • choking
  • convulsion
  • drug ineffective
  • dysphagia
  • hypertension
  • hysterectomy
  • insomnia
  • malaise
not specified:
  • convulsion
  • headache
  • hypertension
  • nausea
  • vomiting
  • insomnia
  • muscular weakness
  • cough
  • pyrexia
  • drug ineffective

Most common drug interactions by gender *:

female:
  • convulsion
  • cough
  • hypertension
  • insomnia
  • nausea
  • headache
  • vomiting
  • pyrexia
  • muscular weakness
  • anaemia
male:
  • convulsion
  • headache
  • hypotension
  • vomiting
  • abdominal pain
  • hypertension
  • nausea
  • agitation
  • blood magnesium decreased
  • drug ineffective

Most common drug interactions by age *:

0-1:
  • peritonitis bacterial
  • sepsis
  • status epilepticus
  • amniotic fluid volume decreased
  • atrial septal defect
  • bicuspid aortic valve
  • breech presentation
  • dilatation ventricular
  • foetal exposure during pregnancy
  • grunting
2-9:
  • hypertension
  • abdominal pain
  • agitation
  • amaurosis
  • aphasia
  • ataxia
  • cardiac arrest
  • chronic respiratory failure
  • coma
  • convulsion
10-19:
  • affective disorder
  • drug dependence
  • drug rash with eosinophilia and systemic symptoms
  • acute lymphocytic leukaemia recurrent
  • capillary leak syndrome
  • chronic graft versus host disease
  • cystitis haemorrhagic
  • diarrhoea
  • drug toxicity
  • engraft failure
20-29:
  • cardiac arrest
  • cardiac tamponade
  • pericardial effusion
  • fatigue
  • supraventricular tachycardia
  • disseminated intravascular coagulation
  • multi-organ failure
  • weakness
  • convulsion
  • cytomegalovirus infection
30-39:
  • agitation
  • hypotension
  • torsade de pointes
  • ventricular extrasystoles
  • headache
  • blood creatine phosphokinase increased
  • blood magnesium decreased
  • blood potassium decreased
  • dyskinesia
  • ataxia
40-49:
  • convulsion
  • headache
  • nausea
  • vomiting
  • abdominal pain
  • blood pressure decreased
  • blood pressure increased
  • erythema
  • pyrexia
  • asthenia
50-59:
  • convulsion
  • insomnia
  • hypertension
  • vomiting
  • cough
  • nausea
  • cellulitis
  • muscular weakness
  • anaemia
  • headache
60+:
  • stevens-johnson syndrome
  • toxic epidermal necrolysis
  • death
  • anxiety
  • headache
  • completed suicide
  • convulsion
  • tremor
  • anaemia
  • cough

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Dilantin and Atarax?

Can you answer these questions?

More questions for: Dilantin, Atarax

You may be interested in these reviews

More reviews for: Dilantin, Atarax

On eHealthMe, Dilantin (phenytoin) is often used to treat convulsion. Atarax (hydroxyzine hydrochloride) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.